# Jeng‐Sen Tseng

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jeng-sen-tseng/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,436 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 22 |
| i10-index | 43 |
| Last Known Institution | National Yang Ming Chiao Tung University |
| OpenAlex ID | https://openalex.org/A5075713583 |
| ORCID iD | 0000-0003-2341-4495 |
| Works | 88 |

## Researcher papers

- [CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues](https://scholariq.org/papers/castp-computed-atlas-of-surface-topography-of-proteins-with-structural-and/)
- [The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan](https://scholariq.org/papers/the-relationship-between-air-pollution-and-lung-cancer-in-nonsmokers-in-taiwan/)
- [Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan](https://scholariq.org/papers/identification-of-five-driver-gene-mutations-in-patients-with-treatment-naive/)
- [High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients](https://scholariq.org/papers/high-pd-l1-expression-correlates-with-primary-resistance-to-egfr-tkis-in/)
- [R331W Missense Mutation of Oncogene <i>YAP1</i> Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability](https://scholariq.org/papers/r331w-missense-mutation-of-oncogene-i-yap1-i-is-a-germline-risk-allele-for-lung/)
- [EGFR mutation, smoking, and gender in advanced lung adenocarcinoma](https://scholariq.org/papers/egfr-mutation-smoking-and-gender-in-advanced-lung-adenocarcinoma/)
- [Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/dynamic-plasma-egfr-mutation-status-as-a-predictor-of-egfr-tki-efficacy-in/)
- [The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma](https://scholariq.org/papers/the-association-of-acquired-t790m-mutation-with-clinical-characteristics-after/)
- [Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018](https://scholariq.org/papers/association-of-smoking-with-patient-characteristics-and-outcomes-in-small-cell/)
- [PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients](https://scholariq.org/papers/pd-l1-strong-expressions-affect-the-clinical-outcomes-of-osimertinib-in/)
- [Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/histological-transformation-after-acquired-resistance-to-the-third-generation/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [National Yang Ming Chiao Tung University](https://scholariq.org/institutions/national-yang-ming-chiao-tung-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.